Perfusion Decellularized ECM Scaffolds for 3D Cell Culture

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current stem cell differentiation and primary cell culture in 2D conditions are limited in retaining functional cellular phenotypes and supporting high-density cell culture and long-term primary or differentiated cell function, leading to cells lacking essential functional properties for in vitro or in vivo applications.

Innovation Solution

The use of perfusion decellularized organ- or tissue-derived extracellular matrix (ECM) as a 3D scaffold to support organ- or tissue-specific cellular differentiation and maturation of stem or progenitor cells, or maintenance of differentiated cells, which retains native microstructure and provides a niche environment for functional differentiation and maintenance.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If 2D culture conditions are used for stem cell differentiation and primary cell culture, then cell expansion is achieved, but functional cellular phenotypes are lost and long-term cell function is not supported

Engineering Contradiction:
Improvecell expansionVSAvoidfunctional cellular phenotype
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent transitions from 2D culture conditions to 3D perfusion bioreactor systems. The decellularized ECM scaffolds provide a three-dimensional architecture that better mimics the native tissue microenvironment, enabling cells to maintain functional phenotypes while expanding. The 3D structure allows for improved cell-cell and cell-matrix interactions that are lost in 2D culture.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Solution Approach 2:

The patent employs perfusion bioreactors that control multiple parameters including flow rate, pressure, oxygen concentration, and nutrient delivery. These parameter changes create optimized culture conditions that maintain cellular functionality during expansion. The dynamic perfusion system delivers growth factors and removes waste products more effectively than static 2D culture.

Inventive Principle:
Principle #35Parameter changes

2Ease of operation

If 2D culture conditions are used, then cell culture is simplified, but high-density cell culture and long-term primary or differentiated cell function are not supported

Engineering Contradiction:
Improvecell culture simplicityVSAvoidlong-term cell function
Core Design Contradiction:
Ease of operationVSDuration of action of stationary object

Solution Approach 1:

The decellularized ECM scaffolds provide self-organizing structural support and biochemical cues that guide cell behavior without requiring complex external intervention. The scaffolds naturally retain native tissue architecture including vascular structures, which automatically facilitate nutrient delivery and waste removal, enabling long-term culture functionality.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The perfusion bioreactor system provides continuous delivery of nutrients, growth factors, and oxygen while continuously removing metabolic waste. This continuous action maintains optimal cellular conditions for extended periods, supporting long-term primary and differentiated cell function that cannot be achieved in batch 2D culture systems.

Inventive Principle:
Principle #20Continuity of useful action

3Reliability

If perfusion decellularized ECM is used as a 3D scaffold, then functional cellular differentiation and high-density cell culture are supported, but system complexity increases

Engineering Contradiction:
Improvefunctional cellular differentiationVSAvoidsystem complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The decellularization process is performed in advance to prepare the ECM scaffolds before cell seeding. This preliminary action removes cellular material while preserving the extracellular matrix architecture, creating ready-to-use scaffolds that simplify subsequent cell culture operations. The scaffolds are pre-characterized for their structural and biochemical properties.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The decellularized ECM acts as an intermediary between the perfusion bioreactor system and the living cells. It translates the mechanical and biochemical inputs from the perfusion system into appropriate cellular responses, mediating the complex interactions between the engineered system and biological cells.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Stability of the object's composition

If perfusion decellularized ECM is used, then native microstructure is retained and niche environment is provided, but manufacturing complexity increases

Engineering Contradiction:
Improvenative microstructureVSAvoidmanufacturing complexity
Core Design Contradiction:
Stability of the object's compositionVSEase of manufacture

Solution Approach 1:

The decellularization process selectively discards cellular material (nuclei, cytoplasm, organelles) while recovering and preserving the extracellular matrix structure. Detergents and enzymes are used to remove cells, and the process is optimized to retain native microstructure, collagen organization, and biochemical signaling molecules for subsequent recellularization.

Inventive Principle:
Principle #34Discarding and recovering

Solution Approach 2:

The perfusion bioreactor system serves multiple functions: it delivers nutrients and growth factors, removes waste products, applies mechanical stimulation through fluid flow, and controls oxygen tension. This multi-functionality consolidates what would otherwise require multiple separate systems into a single integrated platform.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentEP2588592B1Use of perfusion decellularized organs for matched recellularization
Publication Date: 2017.09.06 MIROMATRIX MEDICAL INC
  • EP2588592B1 patent drawingFigure 1A~1C
  • EP2588592B1 patent drawingFigure 2A~2B
  • EP2588592B1 patent drawingFigure 3A~3D

AI summary

The invention provides a method for preparing a perfusion based 3D cell culture system, a recellularized matrix culture system, and methods of using the culture system.